In murine models, butyrate was shown to inhibit anti‐CTLA‐4‐induced upregulation of CD80/CD86 on DCs and ICOS (CD278) on T cells, as well as suppress the accumulation of tumor‐specific and memory T cells. The gene discussed is ICOS; the disease is neoplasm.